10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001513160-13-000062`
Period End Date	20130630
Filing Date	20131023
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	gnpb-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 78 Cash Flow Statement 115 Stockholders Equity 11

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	-	USD	Point-in-time
Cash and cash equivalents	`Cash`	$569.58K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$8.91K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$12.02K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$5.00K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$5.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.27K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.13K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	18.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.28K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$578.72K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	18.00M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $12,020 and $8,915	`PropertyPlantAndEquipmentNet`	$22.14K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $12,020 and $8,915	`PropertyPlantAndEquipmentNet`	$19.03K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	13.33M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	818,806.00	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	818,806.00	shares	Point-in-time
Total assets	`Assets`	$29.41K	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	13.33M	shares	Point-in-time
Total assets	`Assets`	$597.75K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.48M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.89M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.74M	USD	Point-in-time
7% convertible promissory notes	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
7% convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	-	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	$1.23M	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	$250.00K	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	-	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	$2.03M	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.35M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.37M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 18,000,000 shares authorized, 13,332,315 and 818,806 shares issued and outstanding, respectively	`CommonStockValue`	$556.00	USD	Point-in-time
Common stock, $0.000041666 par value; 18,000,000 shares authorized, 13,332,315 and 818,806 shares issued and outstanding, respectively	`CommonStockValue`	$34.00	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common stock subscribed for, 400,000 shares	`CommonStockSharesSubscribedButUnissued`	400,000.00	shares	Point-in-time
Common stock subscribed for, 400,000 shares	`CommonStockSharesSubscribedButUnissued`	-	shares	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$31.74M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-35.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.68M	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$-2.77M	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$29.41K	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$597.75K	USD	Point-in-time

Income Statement 78 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	23 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Revenues	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$87.39K	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$133.03K	USD	2 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$16.31M	USD	23 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$1.70M	USD	2 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$469.49K	USD	1 Quarter
Operating expenses (including $87,386, $469,486, 133,032, $1,696,712 and $16,312,129 in share based compensation costs)	`OperatingCostsAndExpenses`	$27.71M	USD	23 Qtrs
Operating expenses (including $87,386, $469,486, 133,032, $1,696,712 and $16,312,129 in share based compensation costs)	`OperatingCostsAndExpenses`	$1.21M	USD	2 Qtrs
Operating expenses (including $87,386, $469,486, 133,032, $1,696,712 and $16,312,129 in share based compensation costs)	`OperatingCostsAndExpenses`	$1.38M	USD	1 Quarter
Operating expenses (including $87,386, $469,486, 133,032, $1,696,712 and $16,312,129 in share based compensation costs)	`OperatingCostsAndExpenses`	$779.26K	USD	1 Quarter
Operating expenses (including $87,386, $469,486, 133,032, $1,696,712 and $16,312,129 in share based compensation costs)	`OperatingCostsAndExpenses`	$3.63M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$250.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$520.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.16M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$270.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.10M	USD	23 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	2 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	2 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	23 Qtrs
Total costs and expenses	`OperatingExpenses`	$4.78M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$31.98M	USD	23 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.65M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$1.73M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.03M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-31.98M	USD	23 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.65M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.78M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.03M	USD	1 Quarter
Interest expense	`InterestExpense`	$445.74K	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.52M	USD	23 Qtrs
Interest expense	`InterestExpense`	$110.81K	USD	1 Quarter
Interest expense	`InterestExpense`	$199.28K	USD	2 Qtrs
Interest expense	`InterestExpense`	$104.13K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	-	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	$10.00M	USD	23 Qtrs
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	$1.93M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	$-620.24K	USD	2 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$497.89K	USD	2 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$497.89K	USD	1 Quarter
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.50M	USD	23 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	1 Quarter
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	2 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	1 Quarter
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	23 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	2 Qtrs
Financing costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Financing costs	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Financing costs	`AmortizationOfFinancingCosts`	$2.87M	USD	23 Qtrs
Financing costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Financing costs	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$1.32M	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-2.40M	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-3.18M	USD	23 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-2.74M	USD	2 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-1.32M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-6.10M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-35.16M	USD	23 Qtrs
Net Loss	`NetIncomeLoss`	$-327.28K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.43M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.48M	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	782,931.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.24M	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	782,149.00	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.90M	shares	2 Qtrs

Cash Flow Statement 115 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-35.16M	USD	23 Qtrs
Net loss	`NetIncomeLoss`	$-327.28K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.48M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$73.39K	USD	23 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.11K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.10K	USD	2 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	2 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	2 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	23 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$4.66M	USD	23 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$1.65M	USD	2 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$220.42K	USD	2 Qtrs
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	2 Qtrs
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	$2.99M	USD	23 Qtrs
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	2 Qtrs
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	2 Qtrs
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	2 Qtrs
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	$2.56M	USD	23 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	2 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.00M	USD	23 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	2 Qtrs
Common shares to be issued with 12% promissiory notes	`CommonSharesToBeIssuedWithPromissioryNotes`	$497.89K	USD	2 Qtrs
Common shares to be issued with 12% promissiory notes	`CommonSharesToBeIssuedWithPromissioryNotes`	-	USD	23 Qtrs
Common shares to be issued with 12% promissiory notes	`CommonSharesToBeIssuedWithPromissioryNotes`	-	USD	2 Qtrs
Private placement costs	`PrivatePlacementCosts1`	-	USD	2 Qtrs
Private placement costs	`PrivatePlacementCosts1`	-	USD	2 Qtrs
Private placement costs	`PrivatePlacementCosts1`	$385.00K	USD	23 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-620.24K	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$10.00M	USD	23 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	2 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	23 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$50.00K	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.30M	USD	23 Qtrs
Common stock issued conversion of warrants	`CommonStockIssuedConversionOfWarrants`	-	USD	2 Qtrs
Common stock issued conversion of warrants	`CommonStockIssuedConversionOfWarrants`	$122.73K	USD	23 Qtrs
Common stock issued conversion of warrants	`CommonStockIssuedConversionOfWarrants`	$122.73K	USD	2 Qtrs
Common stock issued for repricing shares	`CommonStockIssuedforRepricingShares`	-	USD	2 Qtrs
Common stock issued for repricing shares	`CommonStockIssuedforRepricingShares`	$2.17M	USD	23 Qtrs
Common stock issued for repricing shares	`CommonStockIssuedforRepricingShares`	$2.17M	USD	2 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	2 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	2 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	23 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	2 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	23 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	2 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.13K	USD	23 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-5.24K	USD	2 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.86K	USD	2 Qtrs
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$5.84M	USD	23 Qtrs
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$700.06K	USD	2 Qtrs
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$976.32K	USD	2 Qtrs
Accrued expenses - National Institute of Health	`IncreaseDecreaseInAccruedLiabilities`	-	USD	2 Qtrs
Accrued expenses - National Institute of Health	`IncreaseDecreaseInAccruedLiabilities`	$616.00K	USD	2 Qtrs
Accrued expenses - National Institute of Health	`IncreaseDecreaseInAccruedLiabilities`	-	USD	23 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.96M	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-981.93K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.11M	USD	23 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$35.05K	USD	23 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	23 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	2 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	2 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-85.05K	USD	23 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$311.50K	USD	2 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.93M	USD	23 Qtrs
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.48M	USD	23 Qtrs
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	-	USD	2 Qtrs
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.22M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.00K	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.24M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.33M	USD	23 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	23 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	2 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.55M	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.47M	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$10.76M	USD	23 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-494.48K	USD	2 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$569.58K	USD	2 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$569.58K	USD	23 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$569.58K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$15.54K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.02K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$569.58K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$15.54K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.02K	USD	Point-in-time
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	23 Qtrs
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	2 Qtrs
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	2 Qtrs
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$1.90M	USD	23 Qtrs
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$182.08K	USD	2 Qtrs
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	2 Qtrs
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	23 Qtrs
Common stock issued for intellectual property	`StockIssued1`	-	USD	2 Qtrs
Common stock issued for intellectual property	`StockIssued1`	-	USD	2 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	23 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	2 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	2 Qtrs
Common stock issued upon conversion of convertible notes, accrued interest and penalty	`DebtConversionOriginalDebtAmount1`	$9.27M	USD	23 Qtrs
Common stock issued upon conversion of convertible notes, accrued interest and penalty	`DebtConversionOriginalDebtAmount1`	$9.27M	USD	2 Qtrs

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquity`	$-2.77M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Common stock issued in settlement of notes payable and accrued interest and penalty, Amount	`DebtConversionOriginalDebtAmount1`	$9.27M	USD	23 Qtrs
Common stock issued in settlement of notes payable and accrued interest and penalty, Amount	`DebtConversionOriginalDebtAmount1`	$9.27M	USD	2 Qtrs
Common stock issued for cash under the restructuring, Amount	`StockIssuedDuringPeriodValueOther`	$1.24M	USD	2 Qtrs
Fair value of common stock issued for cancellation of outstanding warrants, Amount	`FairValueOfCommonStockIssuedForCancellationOfOutstandingWarrantsAmount`	$122.73K	USD	2 Qtrs
Fair value of vested stock options and warrants, Amount	`FairValueOfVestedStockOptionsAndWarrantsAmount`	$220.42K	USD	2 Qtrs
Fair value of additional Common Stock granted in exchange transaction, $1.00 per share, Amount	`FairValueOfAdditionalCommonStockGrantedInExchangeTransaction1.00PerShareAmount`	$2.17M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.48M	USD	2 Qtrs
Ending Balance Amount	`StockholdersEquity`	$-2.77M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.